KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Net Margin: 2010-2025

Historic Net Margin for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -287.29%.

  • Novavax's Net Margin fell 14376.00% to -287.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.16%, marking a year-over-year increase of 6634.00%. This contributed to the annual value of -27.49% for FY2024, which is 2792.00% up from last year.
  • Per Novavax's latest filing, its Net Margin stood at -287.29% for Q3 2025, which was down 572.03% from 60.86% recorded in Q2 2025.
  • Novavax's Net Margin's 5-year high stood at 77.80% during Q1 2025, with a 5-year trough of -380.87% in Q4 2021.
  • Its 3-year average for Net Margin is -89.33%, with a median of -69.94% in 2023.
  • Per our database at Business Quant, Novavax's Net Margin soared by 71,609bps in 2021 and then tumbled by 39,196bps in 2023.
  • Quarterly analysis of 5 years shows Novavax's Net Margin stood at -380.87% in 2021, then soared by 32,987bps to -50.99% in 2022, then plummeted by 1,024bps to -61.23% in 2023, then tumbled by 3,053bps to -91.76% in 2024, then crashed by 14,376bps to -287.29% in 2025.
  • Its last three reported values are -287.29% in Q3 2025, 60.86% for Q2 2025, and 77.80% during Q1 2025.